Filing Details

Accession Number:
0001209191-12-053845
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-19 18:00:32
Reporting Period:
2012-11-15
Filing Date:
2012-11-19
Accepted Time:
2012-11-19 18:00:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Biotime Inc BTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229339 D Alfred Kingsley 150 E. 57Th Street
New York NY 10022
See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Disposition 2012-11-15 344,828 $2.90 7,167,566 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares, No Par Value 1,968,505 Indirect By Greenbelt Corp.
Common Shares, No Par Value 490,373 Indirect By Greenway Partners, LP
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option to Puchase Common Shares $4.60 2017-06-30 50,000 50,000 Direct
Common Shares Option to Puchase Common Shares $5.13 2016-06-30 50,000 50,000 Direct
Common Shares Option to Puchase Common Shares $5.45 2015-08-09 50,000 50,000 Direct
Common Shares Option to Puchase Common Shares $2.30 2014-07-01 50,000 50,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-06-30 50,000 50,000 Direct
2016-06-30 50,000 50,000 Direct
2015-08-09 50,000 50,000 Direct
2014-07-01 50,000 50,000 Direct
Footnotes
  1. On November 15, 2012, Mr. Kingsley sold 344,828 BioTime common shares in a private transaction.
  2. Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
  3. 12,500 options became exercisable on September 30, 2012 and the remaining 37,500 options will become exercisable in 3 equal quarterly installments based upon continued service on the board of directors.
  4. 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
  5. 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
  6. 12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.